A phase Ib/II and pharmacokinetic study of EP0057 (formerly CRLX101) in combination with weekly paclitaxel in patients with recurrent or persistent epithelial ovarian, fallopian tube, or primary peritoneal cancer
L. R. Duska, C. N. Krasner, D. M. O'Malley, J. L. Hays, S. C. Modesitt, C. A. Mathews, K. N. Moore, P. H. Thaker, A. Miller, C. Purdy, W. C. Zamboni, A. T. Lucas, J. G. Supko, R. J. Schilder
Dive into the research topics of 'A phase Ib/II and pharmacokinetic study of EP0057 (formerly CRLX101) in combination with weekly paclitaxel in patients with recurrent or persistent epithelial ovarian, fallopian tube, or primary peritoneal cancer'. Together they form a unique fingerprint.